Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

British Journal of Cancer
J Dose-SchwarzN Avril

Abstract

The aim of this was to evaluate FDG-PET (2-(fluorine-18)-fluoro-2-deoxy-D-glucose positron emission tomography) for assessment of residual tumour after primary chemotherapy of large and locally advanced breast cancer in comparison with conventional imaging modalities. In a prospective multicentre trial, 99 patients underwent one or more breast imaging modalities before surgery in addition to clinical examination, namely, FDG-PET (n=89), mammography (n=47), ultrasound (n=46), and magnetic resonance imaging (MRI) (n=46). The presence of residual tumour by conventional imaging, dichotomised as positive or negative, and the level of FDG uptake (standardised uptake values, SUV) were compared with histopathology, which served as the reference standard. Patients with no residual tumour or only small microscopic foci of residual tumour were classified as having minimal residual disease and those with extensive microscopic and macroscopic residual tumour tissue were classified as having gross residual disease. By applying a threshold SUV of 2.0, the sensitivity of FDG-PET for residual tumour was 32.9% (specificity, 87.5%) and increased to 57.5% (specificity, 62.5%) at a threshold SUV of 1.5. Conventional imaging modalities were more sen...Continue Reading

References

Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G BonadonnaM Zambetti
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KuererS E Singletary
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L EssermanE Sickles
Oct 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N AvrilM Schwaiger
Nov 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A van der HageL Duchateau
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J BurcombeW L Wong
Oct 22, 2002·AJR. American Journal of Roentgenology·Savannah C PartridgeNola M Hylton
Feb 26, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Karoline SpaepenChristine De Wolf-Peeters
Oct 24, 2003·AJR. American Journal of Roentgenology·Eric L RosenMark W Dewhirst
Mar 6, 2004·Breast Cancer Research and Treatment·Laura MartincichMassimo Aglietta
Nov 4, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F DenisL Brunereau
Apr 12, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry D BearNorman Wolmark
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malik E JuweidUNKNOWN Imaging Subcommittee of International Harmonization Project in Lymphoma
Jul 21, 2007·Journal of Surgical Oncology·Davendra SegaraMehra Golshan
Jan 26, 2008·British Journal of Cancer·M BhattacharyyaC J Gallagher
Feb 22, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·James W FletcherAnthony F Shields
Mar 22, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S MahnerJ Dose-Schwarz
Oct 23, 2008·Topics in Magnetic Resonance Imaging : TMRI·Wendy DeMartini, Constance Lehman
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jörg Schwarz-DoseNorbert Avril
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael UntchGottfried E Konecny
Apr 22, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Norbert AvrilRebecca Roylance

❮ Previous
Next ❯

Citations

May 24, 2011·World Journal of Clinical Oncology·Kijoon Lee
Jan 9, 2013·Journal of the National Cancer Institute·Michael L MarinovichStefano Ciatto
Nov 6, 2018·Japanese Journal of Radiology·Hiromi KoyasuMasayuki Matsuo
Dec 3, 2010·Current Opinion in Obstetrics & Gynecology·Abigail S Caudle, Kelly K Hunt
Aug 2, 2015·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Thomas BengtssonAlex J de Crespigny
Apr 30, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Kenneth E PengelKenneth G A Gilhuijs
Oct 1, 2011·Breast Cancer Research and Treatment·Yuting WangGang Huang
Oct 19, 2017·Radiology·Amy M FowlerBonnie N Joe
Feb 3, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Stefanie AvrilNorbert Avril
Apr 18, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·David GroheuxElif Hindié
Jul 15, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Laurence ChampionMyriam Wartski
Jun 14, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Balasubramanian VaitilingamPhilip S Low

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.